Biblio
“Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
, “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, 2023.
, “Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1313-1322, 2023.
, “Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
, “Helicobacter pylori Infection Is Associated with Long-Term Cognitive Decline in Older Adults: A Two-Year Follow-Up Study.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1351-1358, 2023.
, “Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.”, J Alzheimers Dis, 2023.
, “Impaired Early Insulin Response to Glucose Load Predicts Episodic Memory Decline: A 10-Year Population-Based Cohort Follow-Up of 45-74-Year-Old Men and Women.”, J Alzheimers Dis, vol. 92, no. 1, pp. 349-359, 2023.
, “Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
, “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, 2023.
, “Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.”, J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
, “Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study.”, J Alzheimers Dis, vol. 92, no. 1, pp. 295-309, 2023.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
, “Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.”, J Alzheimers Dis, vol. 92, no. 1, pp. 361-369, 2023.
, “3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
, “5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
, “Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-β Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 90, no. 4, pp. 1501-1521, 2022.
, “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.”, J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
, “Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.”, J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
,